Skip to main content
    I

    Innospec Inc (IOSP)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ

    $79.17
    -1.22 (-1.52%)

    Market Cap: $1.98B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Innospec Inc (IOSP) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Innospec (IOSP) trades at 15.5x trailing earnings and 1.0x sales. Its P/E of 15.5x is below its 5-year median of 17.7x. Its forward P/E is 12.3x. The median P/E across 12 similar companies is 17.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 26.0% higher over the next year. Its free cash flow yield is 1.8%.

    MultipleValue
    P/E (trailing)15.5x
    Forward P/E12.3x
    Price to sales1.0x
    Price to book1.4x
    EV/EBITDA8.1x
    Price to FCF55.9x
    EV/FCF48.7x
    PEG0.7
    FCF yield1.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 10.4% below 17.3x, its P/S is 28.6% below 1.4x and its P/B is 39.1% below 2.3x.

    MultipleCurrent5-year median10-year median
    P/E15.5x17.7x17.3x
    P/S1.0x1.3x1.4x
    P/B1.4x2.2x2.3x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 12.8x in 2018 to 28.2x in 2020.

    Year endPriceP/EP/SP/B
    2025$76.5414.4x1.1x1.4x
    2024$110.0618.7x1.5x2.3x
    2023$123.2420.2x1.6x2.7x
    2022$102.8617.0x1.3x2.5x
    2021$90.3418.8x1.5x2.2x
    2020$90.7328.2x1.9x2.4x
    2019$103.4419.7x1.7x2.8x
    2018$61.7612.8x1.0x1.8x
    2017$70.6015.2x1.3x2.2x
    2016$68.5017.9x1.9x2.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IOSP

    What is IOSP's forward P/E ratio?

    Innospec has a forward P/E ratio of 12.3x.

    Is IOSP stock overvalued?

    GNG's valuation label for IOSP is Undervalued. Its P/E of 15.5x compares with a median of 17.6x across 12 similar companies.

    What is IOSP's price to sales ratio?

    Innospec has a price to sales ratio of 1.0x.

    What is Innospec's average P/E ratio over 5 years?

    Innospec's median P/E over the last 5 years is 17.7x, from 60 month-end values through Oct 2026.

    What is IOSP's PEG ratio?

    Innospec has a PEG ratio of 0.7.